Kevon Cream contains Ketoconazole 2% w/w, an imidazole antifungal agent effective against a broad spectrum of dermatophytes, yeasts, and fungi responsible for superficial skin infections. It is primarily indicated for the treatment of cutaneous mycoses such as tinea corporis, tinea cruris, tinea pedis, and pityriasis versicolor. Ketoconazole exerts its antifungal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. Kevon Cream is applied topically to the affected area once or twice daily, depending on the severity and type of infection, and should be used consistently for the full prescribed duration to prevent recurrence. It is generally well tolerated, with adverse effects being rare but may include local irritation, burning sensation, or erythema at the application site. Patients should avoid contact with eyes and mucous membranes and discontinue use if severe irritation develops. Kevon Cream is contraindicated in individuals with known hypersensitivity to ketoconazole or any of the cream’s excipients. It is important to follow healthcare professional guidance for optimal therapeutic outcomes and to minimize the risk of resistance development.